These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 12797927)
1. [Prevalence of infection by HIV and hepatitis C virus in a cohort of patients on methadone treatment]. Esteban J; Gimeno C; Aragonés A; Barril J; Pellín Mde L Med Clin (Barc); 2003 May; 120(20):765-7. PubMed ID: 12797927 [TBL] [Abstract][Full Text] [Related]
2. HIV And HCV infection among opiate-dependent patients and methadone doses: the PROTEUS study. Roncero C; Fuster D; Palma-Álvarez RF; Rodriguez-Cintas L; Martinez-Luna N; Álvarez FJ AIDS Care; 2017 Dec; 29(12):1551-1556. PubMed ID: 28393548 [TBL] [Abstract][Full Text] [Related]
3. Methadone treatment, severe food insecurity, and HIV-HCV co-infection: A propensity score matching analysis. McLinden T; Moodie EEM; Hamelin AM; Harper S; Rossi C; Walmsley SL; Rourke SB; Cooper C; Klein MB; Cox J Drug Alcohol Depend; 2018 Apr; 185():374-380. PubMed ID: 29544189 [TBL] [Abstract][Full Text] [Related]
4. High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan. Ng MH; Chou JY; Chang TJ; Lee PC; Shao WC; Lin TY; Chen VC; Gossop M Addict Behav; 2013 Apr; 38(4):2089-93. PubMed ID: 23403277 [TBL] [Abstract][Full Text] [Related]
5. Trends and factors in human immunodeficiency virus and/or hepatitis C virus testing and infection among injection drug users newly entering methadone maintenance treatment in Guangdong Province, China 2006-2013: a consecutive cross sectional study. Liu Y; Liu Y; Zou X; Chen W; Ling L BMJ Open; 2017 Jul; 7(7):e015524. PubMed ID: 28710214 [TBL] [Abstract][Full Text] [Related]
7. Who uses methadone services in China? Monitoring the world's largest methadone programme. Sullivan SG; Wu Z; Rou K; Pang L; Luo W; Wang C; Cao X; Yin W; Liu E; Mi G; Addiction; 2015 Jan; 110 Suppl 1():29-39. PubMed ID: 25533862 [TBL] [Abstract][Full Text] [Related]
8. Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995. Broers B; Junet C; Bourquin M; Déglon JJ; Perrin L; Hirschel B AIDS; 1998 Oct; 12(15):2059-66. PubMed ID: 9814875 [TBL] [Abstract][Full Text] [Related]
9. Characteristics and outcome of minority group patients in methadone maintenance treatment. Peles E; Schreiber S; Adelson M J Psychoactive Drugs; 2014; 46(4):317-24. PubMed ID: 25188702 [TBL] [Abstract][Full Text] [Related]
10. [Prevalence of HIV and HCV infections in patients receiving methadone maintenance treatment in Kaiyuan, Yunnan]. Pu L; Su Y; Wang G; Bai J Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Aug; 36(8):829-31. PubMed ID: 26714537 [TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus infection and pain sensitivity in patients on methadone or buprenorphine maintenance therapy for opioid use disorders. Tsui JI; Lira MC; Cheng DM; Winter MR; Alford DP; Liebschutz JM; Mao J; Edwards RR; Samet JH Drug Alcohol Depend; 2015 Aug; 153():286-92. PubMed ID: 26048638 [TBL] [Abstract][Full Text] [Related]
12. Risk of QTc prolongation in a cohort of opioid-dependent HIV-infected patients on methadone maintenance therapy. Vallecillo G; Mojal S; Roquer A; Martinez D; Rossi P; Fonseca F; Muga R; Torrens M Clin Infect Dis; 2013 Oct; 57(8):1189-94. PubMed ID: 23899678 [TBL] [Abstract][Full Text] [Related]
13. Trends and risk factors for HIV, HCV and syphilis seroconversion among drug users in a methadone maintenance treatment programme in China: a 7-year retrospective cohort study. Zou X; Ling L; Zhang L BMJ Open; 2015 Aug; 5(8):e008162. PubMed ID: 26297365 [TBL] [Abstract][Full Text] [Related]
14. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy. Palepu A; Tyndall MW; Joy R; Kerr T; Wood E; Press N; Hogg RS; Montaner JS Drug Alcohol Depend; 2006 Sep; 84(2):188-94. PubMed ID: 16542797 [TBL] [Abstract][Full Text] [Related]
15. Full participation in harm reduction programmes is associated with decreased risk for human immunodeficiency virus and hepatitis C virus: evidence from the Amsterdam Cohort Studies among drug users. Van Den Berg C; Smit C; Van Brussel G; Coutinho R; Prins M; Addiction; 2007 Sep; 102(9):1454-62. PubMed ID: 17697278 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus and human immunodeficiency virus-1 co-infection in former heroin addicts in methadone maintenance treatment. Piccolo P; Borg L; Lin A; Melia D; Ho A; Kreek MJ J Addict Dis; 2002; 21(4):55-66. PubMed ID: 12296502 [TBL] [Abstract][Full Text] [Related]
17. Variation in the Viral Hepatitis and HIV Policies and Practices of Methadone Maintenance Programs. Jessop AB; Hom JK; Burke M J Addict Med; 2017; 11(3):191-196. PubMed ID: 28252455 [TBL] [Abstract][Full Text] [Related]
18. Prevalence and behavioural risks for HIV and HCV infections in a population of drug users of Dakar, Senegal: the ANRS 12243 UDSEN study. Leprêtre A; Ba I; Lacombe K; Maynart M; Toufik A; Ndiaye O; Kane CT; Gozlan J; Tine J; Ndoye I; Raguin G; Girard PM J Int AIDS Soc; 2015; 18(1):19888. PubMed ID: 26004637 [TBL] [Abstract][Full Text] [Related]
19. Blood-borne infections in Dublin's opiate users. Fitzgerald M; Barry J; O'Sullivan P; Thornton L Ir J Med Sci; 2001; 170(1):32-4. PubMed ID: 11440409 [TBL] [Abstract][Full Text] [Related]
20. Strategies to control HIV and HCV in methadone maintenance treatment in Guangdong Province, China: a system dynamic modeling study. Zou X; Xu Y; Chen W; Xia Y; Liu Y; Gong C; Ling L Subst Abuse Treat Prev Policy; 2018 Jan; 13(1):1. PubMed ID: 29321039 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]